Tracing the network connecting brca and fanconi anaemia proteins (original) (raw)

• Scully, R. & Livingston, D. M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408, 429–32 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Venkitaraman, A. R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108, 171–182 (2002).
  Article CAS PubMed Google Scholar
• Jasin, M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 21, 8981–8993 (2002).
  CAS PubMed Google Scholar
• D'Andrea, A. D. & Grompe, M. The Fanconi anaemia/BRCA pathway. Nature Rev. Cancer 3, 23–34 (2003).
  CAS Google Scholar
• Antoniou, A. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117–1130 (2003).
  CAS PubMed PubMed Central Google Scholar
• Ford, D. et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 62, 676–689 (1998).
  CAS PubMed PubMed Central Google Scholar
• Nathanson, K. N., Wooster, R. & Weber, B. L. Breast cancer genetics: what we know and what we need. Nature Med. 7, 552–556 (2001).
  CAS PubMed Google Scholar
• Thompson, D. & Easton, D. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am. J. Hum. Genet. 68, 410–419 (2001).
  CAS PubMed PubMed Central Google Scholar
• Thompson, D. & Easton, D. F. Cancer Incidence in BRCA1 mutation carriers. J. Natl Cancer Inst. 94, 1358–1365 (2002).
  CAS PubMed Google Scholar
• Collins, N. et al. Consistent loss of the wild-type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10, 1673–1675 (1995).
  CAS PubMed Google Scholar
• Cornelis, R. S. et al. High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCA1-linked families. The Breast Cancer Linkage Consortium. Genes Chromosom. Cancer 13, 203–210 (1995).
  CAS PubMed Google Scholar
• Howlett, N. G. et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606–609 (2002). This paper reports the first evidence confirming a link between BRCA2 mutations and the FA-D1 complementation group.
  CAS PubMed Google Scholar
• Auerbach, A. D. Fanconi anemia. Dermatol. Clin. 13, 41–49 (1995).
  CAS PubMed Google Scholar
• Alter, B. P. Fanconi's anemia and malignancies. Am. J. Hematol. 53, 99–110 (1996).
  CAS PubMed Google Scholar
• Levitus, M. et al. Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes. Blood 20 Nov 2003 (doi: 10.1182/blood-2003-08-2915).
• de Winter, J. P. et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9, 2665–2674 (2000).
  CAS PubMed Google Scholar
• Meetei, A. R. et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nature Genet. 35, 165–170 (2003). A new FA gene is shown to work as a ubiquitin ligase that is necessary for modification of FANCD2.
  CAS PubMed Google Scholar
• Pace, P. et al. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21, 3414–3423 (2002).
  CAS PubMed PubMed Central Google Scholar
• Taniguchi, T. & D'Andrea, A. D. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood 100, 2457–2462 (2002).
  CAS PubMed Google Scholar
• Garcia-Higuera, I. et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249–262 (2001). The first characterization of the FANCD2 protein shows that it links the FA-protein nuclear complex to nuclear foci occupied by the BRCA1 protein.
  CAS PubMed Google Scholar
• Chen, J. et al. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2, 317–328 (1998).
  CAS PubMed Google Scholar
• Patel, K. J. et al. Involvement of Brca2 in DNA repair. Mol. Cell 1, 347–357 (1998).
  CAS PubMed Google Scholar
• Xu, X. et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389–395 (1999).
  CAS PubMed Google Scholar
• Sonoda, E. et al. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17, 598–608 (1998).
  CAS PubMed PubMed Central Google Scholar
• Yu, V. P. et al. Gross chromosomal rearrangements and genetic exchange between non-homologous chromosomes following BRCA2 inactivation. Genes Dev. 14, 1400–1406 (2000).
  CAS PubMed PubMed Central Google Scholar
• Joenje, H. & Patel, K. J. The emerging genetic and molecular basis of Fanconi anaemia. Nature Rev. Genet. 2, 446–457 (2001).
  CAS PubMed Google Scholar
• West, S. C. Molecular views of recombination proteins and their control. Nature Rev. Mol. Cell Biol. 4, 435–445 (2003).
  CAS Google Scholar
• Moynahan, M. E., Chiu, J. W., Koller, B. H. & Jasin, M. Brca1 controls homology-directed DNA repair. Mol. Cell 4, 511–518 (1999).
  CAS PubMed Google Scholar
• Moynahan, M. E., Pierce, A. J. & Jasin, M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell 7, 263–272 (2001). References 28 and 29 show that BRCA1 and BRCA2 regulate the efficiency with which a chromosomal DSB is repaired by homology-directed mechanisms.
  CAS PubMed Google Scholar
• Kraakman-van der Zwet, M. et al. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell. Biol. 22, 669–679 (2002).
  CAS PubMed PubMed Central Google Scholar
• Cressman, V. L. et al. Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice. Mol. Cell. Biol. 19, 7061–7075 (1999).
  CAS PubMed PubMed Central Google Scholar
• Xu, X., Aprelikova, O., Moens, P., Deng, C. X. & Furth, P. A. Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice. Development 130, 2001–2012 (2003).
  CAS PubMed Google Scholar
• Sharan, S. K. et al. BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development 131, 131–142 (2004).
  CAS PubMed Google Scholar
• Yamamoto, K. et al. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol. 23, 5421–5430 (2003).
  CAS PubMed PubMed Central Google Scholar
• Houghtaling, S. et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev. 17, 2021–2035 (2003).
  CAS PubMed PubMed Central Google Scholar
• Wong, J. C. et al. Targeted disruption of exons 1 to 6 of the fanconi anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum. Mol. Genet. 12, 2063–2076 (2003).
  CAS PubMed Google Scholar
• Wilson, J. B. et al. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange. Carcinogenesis 22, 1939–1946 (2001).
  CAS PubMed Google Scholar
• Takata, M. et al. Chromosomal instability and defective recombinational repair in knock-out mutants of the five Rad51 paralogs. Mol. Cell. Biol. 21, 2858–2866 (2001).
  CAS PubMed PubMed Central Google Scholar
• Wong, A. K., Pero, R., Ormonde, P. A., Tavtigian, S. V. & Bartel, P. L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272, 31941–31944 (1997).
  CAS PubMed Google Scholar
• Chen, P. L. et al. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl Acad. Sci. USA 95, 5287–5292 (1998).
  CAS PubMed PubMed Central Google Scholar
• Davies, A. A. et al. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell 7, 273–282 (2001).
  CAS PubMed Google Scholar
• Pellegrini, L. et al. Insights into DNA recombination from the structure of a RAD51–BRCA2 complex. Nature 420, 287–293 (2002). Together, references 41 and 42 demonstrate the regulation of RAD51 oligomerization by the BRC repeats in BRCA2 and provide a structural basis for this phenomenon.
  CAS PubMed Google Scholar
• Yu, D. S. et al. Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2. Mol. Cell 12, 1029–1041 (2003).
  CAS PubMed Google Scholar
• Yang, H. et al. BRCA2 function in DNA binding and recombination from a BRCA2–DSS1–ssDNA structure. Science 297, 1837–1848 (2002). The structure of a C-terminal domain of BRCA2 demonstrates novel DNA-binding properties that might underlie functions in DNA recombination.
  CAS PubMed Google Scholar
• Shin, D. S. et al. Full-length archaeal Rad51 structure and mutants: mechanisms for RAD51 assembly and control by BRCA2. EMBO J. 22, 4566–4576 (2003).
  CAS PubMed PubMed Central Google Scholar
• Shiloh, Y. ATM and related protein kinases: safeguarding genome integrity. Nature Rev. Cancer 3, 155–168 (2003).
  CAS Google Scholar
• Cortez, D., Wang, Y., Qin, J. & Elledge, S. J. Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science (1999).
• Gatei, M. et al. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J. Biol. Chem. 276, 17276–17280 (2001).
  CAS PubMed Google Scholar
• Tibbetts, R. S. et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14, 2989–3002 (2000).
  CAS PubMed PubMed Central Google Scholar
• Yarden, R. I., Pardo-Reoyo, S., Sgagias, M., Cowan, K. H. & Brody L. C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nature Genet. 30, 285–289 (2002).
  PubMed Google Scholar
• Ree, A. H., Bratland, A., Nome, R. V., Stokke, T. & Fodstad, O. Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1. Oncogene 22, 8952–8955 (2003).
  CAS PubMed Google Scholar
• Lee, J. S., Collins, K. M., Brown, A. L., Lee, C. H. & Chung, J. H. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404, 201–204 (2000).
  CAS PubMed Google Scholar
• Wang, Y. et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14, 927–939 (2000).
  CAS PubMed PubMed Central Google Scholar
• Zhong, Q. et al. Association of BRCA1 with the hRad50–hMre11–p95 complex and the DNA damage response. Science 285, 747–750 (1999).
  CAS PubMed Google Scholar
• Zhong, Q., Chen, C. F., Chen, P. L. & Lee, W. H. BRCA1 facilitates microhomology-mediated end joining of DNA double strand breaks. J. Biol. Chem. 277, 28641–28647 (2002).
  CAS PubMed Google Scholar
• Zhong, Q., Boyer, T. G., Chen, P. L. & Lee, W. H. Deficient nonhomologous end-joining activity in cell-free extracts from _Brca1_-null fibroblasts. Cancer Res. 62, 3966–3970 (2002).
  CAS PubMed Google Scholar
• Li, S. et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature 406, 210–215 (2000).
  CAS PubMed Google Scholar
• Zheng, L. et al. Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol. Cell 6, 757–768 (2000).
  CAS PubMed Google Scholar
• Harkin, D. P. et al. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97, 575–586 (1999).
  CAS PubMed Google Scholar
• Kleiman, F. E. & Manley, J. L. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science 285, 1576–1579 (1999).
  CAS PubMed Google Scholar
• Kleiman, F. E. & Manley, J. L. The BARD1–CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression. Cell 104, 743–753 (2001).
  CAS PubMed Google Scholar
• Scully, R. et al. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl Acad. Sci. USA 94, 5605–5610 (1997).
  CAS PubMed PubMed Central Google Scholar
• Anderson, S. F., Schlegel, B. P., Nakajima, T., Wolpin, E. S. & Parvin, J. D. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nature Genet. 19, 254–256 (1998).
  CAS PubMed Google Scholar
• Bochar, D. A. et al. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102, 257–265 (2000).
  CAS PubMed Google Scholar
• Cantor, S. B. et al. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell 105, 149–160 (2001).
  CAS PubMed Google Scholar
• Ganesan, S. et al. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 111, 393–405 (2002). An intriguing insight into a possible function for BRCA1 in X-chromosome inactivation, which sheds light on the pathogenesis of breast and ovarian cancers that are associated with BRCA1 inactivation.
  CAS PubMed Google Scholar
• Hashizume, R. et al. The ring heterodimer brca1–bard1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276, 14537–14540 (2001).
  CAS PubMed Google Scholar
• Ruffner, H., Joazeiro, C. A., Hemmati, D., Hunter, T. & Verma, I. M. Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl Acad. Sci. USA 98, 5134–5139 (2001).
  CAS PubMed PubMed Central Google Scholar
• Brzovic, P. S., Rajagopal, P., Hoyt, D. W., King, M. C. & Klevit, R. E. Structure of a BRCA1–BARD1 heterodimeric RING–RING complex. Nature Struct. Biol. 8, 833–837 (2001).
  CAS PubMed Google Scholar
• Folias, A. et al. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum. Mol. Genet. 11, 2591–2597 (2002).
  CAS PubMed Google Scholar
• Vandenberg, C. J. et al. BRCA1-independent ubiquitination of FANCD2. Mol. Cell 12, 247–254 (2003).
  CAS PubMed Google Scholar
• Dong, Y. et al. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol. Cell 12, 1087–1099 (2003).
  CAS PubMed Google Scholar
• Mallery, D. L., Vandenberg, C. J. & Hiom, K. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J. 21, 6755–6762 (2002).
  CAS PubMed PubMed Central Google Scholar
• Nishikawa, H. et al. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1–BARD1 ubiquitin ligase. J. Biol. Chem. 279, 3916–3924 (2003).
  PubMed Google Scholar
• Xia, Y., Pao, G. M., Chen, H. W., Verma, I. M. & Hunter, T. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J. Biol. Chem. 278, 5255–5263 (2003).
  CAS PubMed Google Scholar
• Foray, N. et al. A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. EMBO J. 22, 2860–2871 (2003).
  CAS PubMed PubMed Central Google Scholar
• Taniguchi, T. et al. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109, 459–472 (2002).
  CAS PubMed Google Scholar
• Nakanishi, K. et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nature Cell Biol. 4, 913–920 (2002).
  CAS PubMed Google Scholar
• Pichierri, P. & Rosselli, F. The DNA crosslink-induced S-phase checkpoint depends on ATR–CHK1 and ATR–NBS1–FANCD2 pathways. EMBO J. 23, 1178–1187 (2004).
  CAS PubMed PubMed Central Google Scholar
• Centurion, S. A., Kuo, H. R. & Lambert, W. C. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp. Cell Res. 260, 216–221 (2000).
  CAS PubMed Google Scholar
• Sala-Trepat, M. et al. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp. Cell Res. 260, 208–215 (2000).
  CAS PubMed Google Scholar
• Akkari, Y. M., Bateman, R. L., Reifsteck, C. A., Olson, S. B. & Grompe, M. DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links. Mol. Cell. Biol. 20, 8283–8289 (2000).
  CAS PubMed PubMed Central Google Scholar
• Cox, M. M. et al. The importance of repairing stalled replication forks. Nature 404, 37–41 (2000).
  CAS PubMed Google Scholar
• McGlynn, P. & Lloyd, R. G. Recombinational repair and restart of damaged replication forks. Nature Rev. Mol. Cell Biol. 3, 859–870 (2002).
  CAS Google Scholar
• Broomfield, S., Hryciw, T. & Xiao, W. DNA postreplication repair and mutagenesis in Saccharomyces cerevisiae. Mutat. Res. 486, 167–184 (2001).
  CAS PubMed Google Scholar
• Lehmann, A. R. Replication of damaged DNA. Cell Cycle 2, 300–302 (2003).
  CAS PubMed Google Scholar
• Hochegger, H., Sonoda, E. & Takeda, S. Post-replication repair in DT40 cells: translesion polymerases versus recombinases. Bioessays 26, 151–158 (2004).
  CAS PubMed Google Scholar
• Goodman, M. F. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu. Rev. Biochem. 71, 17–50 (2002).
  CAS PubMed Google Scholar
• Hoege, C., Pfander, B., Moldovan, G. L., Pyrowolakis, G. & Jentsch, S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135–141 (2002).
  CAS PubMed Google Scholar
• Tutt, A. N., van Oostrom, C. T., Ross, G. M., van Steeg, H. & Ashworth, A. Disruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation. EMBO Rep. 3, 255–260 (2002).
  CAS PubMed PubMed Central Google Scholar
• Laquerbe, A., Sala-Trepat, M., Vives, C., Escarceller, M. & Papadopoulo, D. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients. Mutat. Res. 431, 341–350 (1999).
  CAS PubMed Google Scholar
• Telleman, P., Overkamp, W. J. & Zdzienicka, M. Z. Spectrum of spontaneously occurring mutations in the HPRT gene of the Chinese hamster V79 cell mutant V-H4, which is homologous to Fanconi anemia group A. Mutagenesis 11, 155–159 (1996).
  CAS PubMed Google Scholar
• Papadopoulo, D., Guillouf, C., Mohrenweiser, H. & Moustacchi, E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc. Natl Acad. Sci. USA 87, 8383–8387 (1990).
  CAS PubMed PubMed Central Google Scholar
• Papadopoulo, D., Porfirio, B. & Moustacchi, E. Mutagenic response of Fanconi's anemia cells from a defined complementation group after treatment with photoactivated bifunctional psoralens. Cancer Res. 50, 3289–3294 (1990).
  CAS PubMed Google Scholar
• Simpson, L. J. & Sale, J. E. Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. EMBO J. 22, 1654–1664 (2003).
  CAS PubMed PubMed Central Google Scholar
• Sonoda, E. et al. Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. EMBO J. 22, 3188–3197 (2003).
  CAS PubMed PubMed Central Google Scholar
• Offit, K. et al. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. J. Natl Cancer Inst. 95, 1548–1551 (2003). This work defines the unique clinical features of a syndrome that is associated with biallelic germline mutations in BRCA2 , indicating that they cause an FA-like disease that differs in some respects from typical FA.
  CAS PubMed Google Scholar